| abstract |
The application belongs to medicinal chemistry arts, there is provided the Pyrrolopyrimidine compounds containing substituted cyclopenta, and in particular to compound, its stereoisomer or its pharmaceutically acceptable salt shown in formula A.The application further relates to prepare the purposes of the method, pharmaceutical composition and the compound of the Pyrrolopyrimidine compounds containing substituted cyclopenta as shown in formula A in the kinase mediated disease for the treatment of Janus. |